Manufacturer record
Sia Pharma Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Sia Pharma Pvt. Ltd (Haryana) were declared Not of Standard Quality between May 2025 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SPD-T116, Calcium Carbonate & Vitamin D3 Tablets (exp May 2027). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay of Vitamin D3 and Uniformity of weight of tablets. Listed in the March 2026 alert.
Records by type
2 records linked to Sia Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium Carbonate & Vitamin D3 Tablets | Batch SPD-T116Mfg Jun 2025 · Exp May 2027 | The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay of Vitamin D3 and Uniformity of weight of tablets.Assay | RDTL, GuwahatiCDSCO lab | Mar 2026 |
| Albendazole Chewable Tablets IP (Alsia-400 Tab | Batch SPD-618Mfg Oct 2024 · Exp Sep 2026 | The sample does not comply with I.P requirement for Dissolution TestDissolution | A.S Kambli Palghar-Zone-1 FDA, Lab MumbaiState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.